RG
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats | Molecular Pharmaceutics | 2020 | 316 | 2 | |||
| Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod | European Journal of Pharmaceutics and Biopharmaceutics | 2019 | 334 | 2 | |||
| Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone Delivery | Otology & Neurotology | 2019 | 397 | 0 | |||
| Effect of implantation site on outcome of tissue-engineered vascular grafts | European Journal of Pharmaceutics and Biopharmaceutics | 2019 | 436 | 1 | |||
| A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapy | International journal of pharmaceutics | 2015 | 907 | 2 | |||
| Controlled drug release from melt-extrudates through processing parameters: A chemometric approach | International journal of pharmaceutics | 2015 | 660 | 0 | |||
| Strategies for formulating and delivering poorly water-soluble drugs | Journal of drug delivery science and technology | 2015 | 847 | 1 | |||
| New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance | European journal of pharmaceutics and biopharmaceutics | 2015 | 686 | 1 | |||
| Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications | Journal of chromatography | 2013 | 665 | 5 | |||
| Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications | European journal of pharmaceutics and biopharmaceutics | 2013 | 688 | 2 | |||
| In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application | Journal of controlled release | 2013 | 629 | 0 | |||
| In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer | Journal of controlled release | 2013 | 671 | 1 | |||
| In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease | European journal of pharmaceutics and biopharmaceutics | 2012 | 712 | 0 | |||
| Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivatives | Carbohydrate Polymers | 2012 | 457 | 0 | |||
| Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model | Biomaterials | 2012 | 778 | 0 | |||
| Advantages of bilayered vascular grafts for surgical applicability and tissue regeneration | Acta biomaterialia | 2012 | 719 | 0 | |||
| Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect | Journal of biomedical materials research. Part A | 2011 | 738 | 0 | |||
| Novel micelle formulations to increase cutaneous bioavailability of azole antifungals | Journal of controlled release | 2011 | 643 | 3 | |||
| The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation | Journal of controlled release | 2010 | 649 | 0 | |||
| Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice | Journal of controlled release | 2010 | 755 | 3 | |||
| Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity | International Journal of Pharmaceutics | 2010 | 424 | 1 | |||
| Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2) | International journal of pharmaceutics | 2010 | 684 | 0 | |||
| Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? | Circulation | 2009 | 655 | 1 | |||
| Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye | Investigative ophthalmology & visual science | 2009 | 608 | 0 | |||
| Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis | Journal of controlled release | 2009 | 720 | 0 | |||
| Novel thermosensitive chitosan hydrogels: in vivo evaluation | Journal of biomedical materials research. Part A | 2009 | 697 | 3 | |||
| Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer | Journal of Drug Targeting | 2009 | 448 | 0 | |||
| Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems | Journal of controlled release | 2009 | 641 | 0 | |||
| A high throughput protein formulation platform: case study of salmon calcitonin | Pharmaceutical research | 2009 | 654 | 684 | |||
| Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts | Journal of biomedical materials research. Part A | 2009 | 588 | 0 | |||
| Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases | European journal of pharmaceutics and biopharmaceutics | 2009 | 676 | 0 | |||
| Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size | European journal of pharmaceutical sciences | 2009 | 662 | 0 | |||
| Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model | Nanomedicine | 2009 | 655 | 0 | |||
| Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity | Journal of Drug Targeting | 2009 | 415 | 1 | |||
| Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells | European journal of pharmaceutical sciences | 2009 | 607 | 0 | |||
| A novel thermoresponsive hydrogel based on chitosan | European journal of pharmaceutics and biopharmaceutics | 2008 | 747 | 1 | |||
| Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound | Drug development and industrial pharmacy | 2008 | 613 | 0 | |||
| High throughput methods to characterize protein permeation and release | International journal of pharmaceutics | 2008 | 848 | 3 | |||
| Colloidal Drug Delivery Systems - Recent Advances With Polymeric Micelles | Chimia | 2008 | 936 | 38 | |||
| Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 519 | 1 | |||
| In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcome | European journal of pharmaceutics and biopharmaceutics | 2008 | 697 | 1 | |||
| A biodegradable drug delivery system for the treatment of postoperative inflammation | International journal of pharmaceutics | 2008 | 533 | 1 | |||
| Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma | Investigative ophthalmology & visual science | 2008 | 695 | 0 | |||
| Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic acid and 5-aminolevulinic acid derivatives | Antimicrobial agents and chemotherapy | 2008 | 762 | 0 | |||
| Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix | Journal of pharmaceutical sciences | 2008 | 655 | 0 | |||
| Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA : PEO Diblock and Triblock Copolymers | Journal of drug targeting | 2008 | 49 | 0 | |||
| Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation | Circulation | 2008 | 659 | 0 | |||
| Nanoparticles for drug delivery : the need for precision in reporting particle size parameters | European journal of pharmaceutics and biopharmaceutics | 2008 | 691 | 2 | |||
| Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles | International journal of pharmaceutics | 2007 | 660 | 0 | |||
| Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation | International journal of pharmaceutics | 2007 | 705 | 7 | |||
| Biological conversion of a water-soluble prodrug of cyclosporine A | European journal of pharmaceutics and biopharmaceutics | 2007 | 647 | 8 | |||
| Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes | Bioconjugate chemistry | 2007 | 654 | 0 | |||
| Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems | Journal of biomedical materials research. Part A | 2007 | 678 | 2 | |||
| Polymeric photosensitizer prodrugs for photodynamic therapy | Photochemistry and photobiology | 2007 | 663 | 0 | |||
| NIR analysis of cellulose and lactose—Application to ecstasy tablet analysis | Forensic science international | 2007 | 945 | 1 | |||
| The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems | Advanced drug delivery reviews | 2007 | 675 | 2 | |||
| Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration | Investigative ophthalmology & visual science | 2007 | 544 | 0 | |||
| Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus | Journal of controlled release | 2007 | 684 | 0 | |||
| Characterization of protein aggregation: the case of a therapeutic immunoglobulin | Biochimica et biophysica acta | 2007 | 643 | 0 | |||
| Detection and characterization of protein aggregates by fluorescence microscopy | International journal of pharmaceutics | 2007 | 650 | 0 | |||
| High throughput screening of protein formulation stability: practical considerations | European journal of pharmaceutics and biopharmaceutics | 2007 | 654 | 0 | |||
| Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats | Molecular vision | 2006 | 79 | 127 | |||
| Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating | AAPS PharmSciTech | 2006 | 584 | 229 | |||
| Biodegradable nanoparticles for direct or two-step tumor immunotargeting | Bioconjugate chemistry | 2006 | 510 | 0 | |||
| Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures | Biomaterials | 2006 | 515 | 1 | |||
| Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer | International journal of pharmaceutics | 2006 | 556 | 1 | |||
| Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides) | International journal of pharmaceutics | 2006 | 570 | 4 | |||
| Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: An EPR imaging study | Journal of controlled release | 2006 | 185 | 0 | |||
| An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical Administration | Drugs in R&D | 2006 | 128 | 122 | |||
| Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH | International journal of pharmaceutics | 2006 | 534 | 1 | |||
| Intraocular implants for extended drug delivery: therapeutic applications | Advanced drug delivery reviews | 2006 | 631 | 1 | |||
| Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates | European journal of pharmaceutics and biopharmaceutics | 2006 | 385 | 1 | |||
| Biodegradable scleral implants as new triamcinolone acetonide delivery systems | International journal of pharmaceutics | 2006 | 490 | 1 | |||
| 5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and Perspectives | Photochemistry and photobiology | 2006 | 94 | 0 | |||
| In vitro and in vivo activities of verteporfin-loaded nanoparticles | Journal of controlled release | 2005 | 185 | 0 | |||
| Coupling Methods to Obtain Ligand-Targeted Liposomes and Nanoparticles | Microencapsulation : methods and industrial applications | 2005 | 67 | 0 | |||
| Conversion of cyclosporine A prodrugs in human tears vs rabbits tears | European journal of pharmaceutics and biopharmaceutics | 2005 | 469 | 0 | |||
| Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the Eye | Chimia | 2005 | 463 | 0 | |||
| A water-soluble prodrug of cyclosporine A for ocular application: A stability study | European journal of pharmaceutical sciences | 2005 | 829 | 718 | |||
| Trans-scleral diffusion of triamcinolone acetonide | Current eye research | 2005 | 545 | 1 | |||
| The use of drug-loaded nanoparticles in cancer chemotherapy | Microencapsulation : Methods and Industrial Applications | 2005 | 62 | 0 | |||
| Pseudo-thermosetting chitosan hydrogels for biomedical application | International journal of pharmaceutics | 2005 | 550 | 1 | |||
| Ecole de Pharmacie Geneve-Lausanne: A novel center of excellence in Geneva | Chimia | 2005 | 393 | 0 | |||
| A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics | International journal of pharmaceutics | 2005 | 540 | 1 | |||
| Synthesis and Ring-Opening Polymerization of New Monoalkyl-Substituted Lactides | Journal of polymer science. Part A, Polymer chemistry | 2004 | 256 | 0 | |||
| Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos | International journal of pharmaceutics | 2004 | 518 | 1 | |||
| Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance | European journal of pharmaceutics and biopharmaceutics | 2004 | 553 | 0 | |||
| New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance | European journal of pharmaceutics and biopharmaceutics | 2004 | 498 | 3 | |||
| Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications | European journal of pharmaceutics and biopharmaceutics | 2004 | 583 | 1 | |||
| Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting | European journal of pharmaceutics and biopharmaceutics | 2004 | 445 | 4 | |||
| Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications | European journal of pharmaceutics and biopharmaceutics | 2004 | 533 | 1 | |||
| Current Methods for Attaching Targeting Ligands to Liposomes and Nanoparticles | Journal of pharmaceutical sciences | 2004 | 173 | 0 | |||
| Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation | Journal of biomedical materials research. Part A | 2003 | 191 | 0 | |||
| Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles | Investigative Ophthalmology & Visual Science | 2003 | 478 | 227 | |||
| Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy | European journal of pharmaceutics and biopharmaceutics | 2003 | 654 | 0 | |||
| Bioadhesive Ophthalmic Drug Inserts (BODI) | Modified-release drug delivery technology | 2003 | 104 | 162 | |||
| In Vitro Monitoring of Poly(ortho ester) Degradation by Electron Paramagnetic Resonance Imaging | Macromolecules | 2003 | 776 | 0 | |||
| Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologies | European journal of pharmaceutics and biopharmaceutics | 2003 | 474 | 1 | |||
| Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic Activity | Photochemistry and photobiology | 2003 | 72 | 0 | |||
| Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans | AAPS PharmSci | 2002 | 572 | 0 | |||
| Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery | Journal of controlled release | 2002 | 519 | 0 | |||
| Ocular tolerance of absorption enhancers in ophthalmic preparations | AAPS PharmSci | 2002 | 457 | 1 | |||
| Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles | International journal of pharmaceutics | 2002 | 472 | 2 | |||
| State of the art in the delivery of photosensitizers for photodynamic therapy | Journal of photochemistry and photobiology. B, Biology | 2002 | 70 | 0 | |||
| Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye | Investigative ophthalmology and visual science | 2002 | 200 | 146 | |||
| Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle | AAPS PharmSci | 2001 | 504 | 0 | |||
| Therapeutic applications of viscous and injectable poly(ortho esters) | Advanced drug delivery reviews | 2001 | 515 | 1 | |||
| Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded Nanoparticles | Pharmaceutical research | 2001 | 56 | 146 | |||
| Fluorescence correlation spectroscopy for the characterisation of drug delivery systems | Biological chemistry | 2001 | 494 | 0 | |||
| Challenges of Intraocular Drug Delivery | European pharmaceutical review | 2001 | 109 | 18 | |||
| Influence of hot-melt extrusion and compression molding on polymer structure organization, investigated by differential scanning calorimetry | Journal of Applied Polymer Science | 2001 | 359 | 0 | |||
| Release of BSA from poly(ortho ester) extruded thin strands | Journal of controlled release | 2001 | 263 | 0 | |||
| A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery | Investigative Ophthalmology & Visual Science | 2001 | 310 | 133 | |||
| Treatment of Intralocular Diseases with Poly(ortho ester)-Based Drug Delivery Systems | Macromolecular symposia | 2001 | 113 | 0 | |||
| pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs | AAPS PharmSci | 2001 | 544 | 0 | |||
| Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation | International journal of pharmaceutics | 2001 | 472 | 1 | |||
| Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket | Biomaterials | 2001 | 472 | 1 | |||
| Protein Release from Poly(ortho ester) Extruded Rods | Macromolecular symposia | 2001 | 83 | 0 | |||
| Development of poly(ortho esters) | Drug delivery systems & sciences | 2001 | 408 | 1 | |||
| Polymeric systems for ophthalmic drug delivery | Polymeric Biomaterials | 2001 | 64 | 0 | |||
| Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles | International journal of pharmaceutics | 2001 | 543 | 1 | |||
| Poly(ortho esters) - A Versatile Drug Delivery System | Biomaterials and Drug Delivery toward New Mellenium | 2000 | 430 | 0 | |||
| Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle Technology | Pharmaceutical research | 2000 | 71 | 190 | |||
| Poly (ortho esters) implants for the sustained delivery of a protein factors influencing the release behaviour of BSA in vitro | The 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference | 2000 | 55 | 92 | |||
| Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state | Journal of controlled release | 2000 | 195 | 0 | |||
| Poly(ortho esters) - their development and some recent applications | European journal of pharmaceutics and biopharmaceutics | 2000 | 542 | 1 | |||
| Local delivery of antimicrobial agents for the treatment of periodontal diseases | European journal of pharmaceutics and biopharmaceutics | 2000 | 439 | 1 | |||
| Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation | Biomaterials | 2000 | 553 | 2 | |||
| A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release | European journal of pharmaceutics and biopharmaceutics | 2000 | 668 | 0 | |||
| Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants | International journal of pharmaceutics | 2000 | 454 | 1 | |||
| A novel analytical approach for the characterization of poly(MePegcyanoacrylate - co - hexadecylcyanoacrylate) nanoparticles | The 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference | 2000 | 53 | 51 | |||
| Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles | Pharmaceutical development and technology | 2000 | 76 | 0 | |||
| Chitosan as Tear Substitute: A Wetting Agent Endowed with Antimicrobial Efficacy | Journal of ocular pharmacology and therapeutics | 2000 | 124 | 0 | |||
| Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses | European journal of pharmaceutics and biopharmaceutics | 2000 | 495 | 1 | |||
| Formation of peptide impurities in polyester matrices during implant manufacturing | European journal of pharmaceutics and biopharmaceutics | 2000 | 604 | 0 | |||
| Formulation and technology aspects of conrolled drug delivery in animals | Pharmaceutical science & technology today | 2000 | 87 | 0 | |||
| Design and development of controlled release veterinary drug delivery systems to the eye | Controlled Release Veterinary Drug Delivery | 2000 | 140 | 0 | |||
| Freeze-drying of PLA-PEO nanoparticles : from basic principles to rational optimization | CRS proceedings | 1999 | 230 | 70 | |||
| Production of biodegradable implants for the sustained release of pharmaceuticals | Asian Conference and Exhibition of Controlled Release | 1999 | 423 | 1 | |||
| Evaluation of the local and systemic inflammatory responses induced by the subcutaneous injection of different biopolymers | CRS proceedings | 1999 | 51 | 50 | |||
| Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymers | CRS proceedings | 1999 | 57 | 39 | |||
| Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention | International journal of pharmaceutics | 1999 | 526 | 1 | |||
| Hydrolysis and Erosion Studies of Autocatalyzed Poly(ortho esters) Containing Lactoyl−Lactyl Acid Dimers | Macromolecules | 1999 | 166 | 0 | |||
| How to avoid the formation of peptide impurities during manufacturing of implants by melt-extrusion ? | CRS proceedings | 1999 | 54 | 55 | |||
| A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application | Journal of biomedical materials research | 1999 | 172 | 226 | |||
| Erosion, properties and drug release from a new family of poly(ortho esters) | Proceedings of the 26th International Symposium on Controlled Release of Bioactive Materials and the Second Conference on Consumer and Diversified Products | 1999 | 45 | 20 | |||
| Poly(ortho esters) | Encyclopedia of controlled drug delivery | 1999 | 114 | 0 | |||
| Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake | Pharmaceutical research | 1999 | 48 | 149 | |||
| Biodegradable implants | Asian Conference and Exhibition of Controlled Release | 1999 | 398 | 58 | |||
| Evaluation of poly(ortho ester) for intraocular application in rabbits: biocompatibility assessment and in vitro degradation | CRS proceedings | 1999 | 65 | 131 | |||
| Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex | European journal of pharmaceutical sciences | 1999 | 519 | 0 | |||
| Poly(ortho ester): a new biocompatible intraocular drug delivery system | Asian Conference and Exhibition of Controlled Release | 1999 | 86 | 30 | |||
| Ocular tolerance of preservatives on the murine cornea | European journal of pharmaceutics and biopharmaceutics | 1999 | 423 | 1 | |||
| Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactate | Journal of biomaterials science. Polymer ed | 1999 | 144 | 0 | |||
| Stability studies of a somatostatin analogue in biodegradable implants | International journal of pharmaceutics | 1999 | 445 | 1 | |||
| Mucosal drug delivery, ocular | Encyclopedia of controlled drug delivery | 1999 | 149 | 0 | |||
| Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants | European journal of pharmaceutics and biopharmaceutics | 1999 | 553 | 3 | |||
| Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization | European journal of pharmaceutics and biopharmaceutics | 1999 | 464 | 2 | |||
| Mucosal drug delivery, intravitreal | Encyclopedia of controlled drug delivery | 1999 | 156 | 0 | |||
| Gamma scintigraphy as tool for the evaluation of precorneal residence time: influence of the methodology | CRS proceedings | 1999 | 49 | 64 | |||
| Nanoparticles | Encyclopedia of controlled drug delivery | 1999 | 207 | 0 | |||
| Protein delivery from extruded poly(ortho esters) | Asian Conference and Exhibition of Controlled Release | 1999 | 399 | 54 | |||
| Application of fluorescence correlation spectroscopy for the characterisation of drug delivery systems | CRS proceedings | 1999 | 53 | 101 | |||
| Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester) | International journal of pharmaceutics | 1999 | 590 | 0 | |||
| Synthesis and characterization of self-catalyzed poly(ortho ester) | Biomaterials | 1998 | 632 | 0 | |||
| Topical use of chitosan in ophthalmology : tolerance assessment by confocal microscopy and precorneal retention evaluation by gamma scintigraphy | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 521 | 2 | |||
| Synthesis and characterization of new bioerodible polymers designed for controlled drug release applications | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 311 | 1 | |||
| pH-Sensitive microparticles as oral delivery systems for antiinfective agents of poor water solubility | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 526 | 1 | |||
| In vitro drug release from self-catalyzed poly(ortho ester): Case study of 5-fluorouracil | Journal of controlled release | 1998 | 196 | 0 | |||
| Injection-moulding versus extrusion for the preparation of long-acting biodegradable implants | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 631 | 1 | |||
| Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental caries | European journal of pharmaceutics and biopharmaceutics | 1998 | 485 | 1 | |||
| Biodegradable polymers for the controlled release of ocular drugs | Progress in polymer science | 1998 | 60 | 0 | |||
| Chitosan: a unique polysaccharide for drug delivery | Drug development and industrial pharmacy | 1998 | 562 | 0 | |||
| A biodegradable polymer designed for concomitant delivery of dexamethasone and 5-fluorouracil to the eye | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 468 | 1 | |||
| Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections | Journal of controlled release | 1998 | 661 | 0 | |||
| Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) containing gentamicin for the treatment of external ophthalmic infections | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 435 | 1 | |||
| Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue | Journal of controlled release | 1998 | 221 | 0 | |||
| Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics | Advanced drug delivery reviews | 1998 | 456 | 0 | |||
| Poly (D,L-lactic acid) nanoparticles as phosphorothioate oligonucleotide carriers in U937 cells | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 450 | 1 | |||
| Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular Tolerance | Journal of ocular pharmacology and therapeutics | 1998 | 138 | 0 | |||
| Bioerodible Polymers for Ocular Drug Delivery | Critical reviews in therapeutic drug carrier systems | 1998 | 155 | 0 | |||
| Influence of irradiation sterilization on a semi-solid poly(ortho ester) | International journal of pharmaceutics | 1998 | 562 | 0 | |||
| Therapeutic applications of retinoids in ophthalmology | International journal of pharmaceutics | 1997 | 439 | 2 | |||
| Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug release | International journal of pharmaceutics | 1997 | 514 | 1 | |||
| Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue | European journal of pharmaceutical sciences | 1997 | 483 | 0 | |||
| Prophylaxis of caries : in vivo evaluation of various oral fluoride containing preparations designed to optimize salivary concentrations | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 68 | 0 | |||
| Influence of Irradiation Sterilization on Polymers Used as Drug Carriers : A Review | Drug development and industrial pharmacy | 1997 | 569 | 1 | |||
| Determination of dexamethasone in tears by capillary electrophoresis | Journal of chromatography. B, Biomedical sciences and applications | 1997 | 521 | 0 | |||
| Confocal Microscopy as a Tool for the Investigation of the Anterior Part of the Eye | Journal of ocular pharmacology and therapeutics | 1997 | 127 | 0 | |||
| Ocular drug delivery in veterinary medicine | Advanced drug delivery reviews | 1997 | 538 | 0 | |||
| PLA-PEG nanoparticles: preparation and cell interaction studies | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 45 | 43 | |||
| In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral use | European journal of pharmaceutics and biopharmaceutics | 1997 | 448 | 1 | |||
| Synthesis and characterization of ointment-like self-catalyzed poly(ortho ester) | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 52 | 217 | |||
| New generation of poly(ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibility | Journal of controlled release | 1997 | 278 | 0 | |||
| Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axis | European journal of pharmaceutics and biopharmaceutics | 1997 | 204 | 0 | |||
| Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations | Pharmaceutica Acta Helvetiae | 1997 | 52 | 0 | |||
| Combined release of dexamethasone and gentamicin from an ocular insert for treatment of external ophthalmic infections | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 89 | 126 | |||
| Development of a long-term delivery system for RC-160, a somatostatin analog | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 50 | 44 | |||
| Uptake of oligonucleotide loaded nanoparticles in prostatic cancer cells and their intracellular localization | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 104 | 107 | |||
| Improved biocompatibility of a viscous bioerodable poly(orthoester) by controlling the environmental pH | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 43 | 157 | |||
| Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement | Journal of biomedical materials research | 1997 | 122 | 0 | |||
| Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticles | Acta pharmaceutica | 1996 | 409 | 112 | |||
| pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs | Pharmaceutical research | 1996 | 47 | 51 | |||
| Basis for Dosing Time-Dependent Changes in the Ocular and Systemic Absorption of Topically Applied Timolol | Journal of ocular pharmacology and therapeutics | 1996 | 133 | 0 | |||
| Development of a Novel Soluble Ophthalmic Insert: Evaluation of Ocular Tolerance in Rabbits | European journal of pharmaceutics and biopharmaceutics | 1996 | 196 | 70 | |||
| Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy Volunteers | Journal of ocular pharmacology and therapeutics | 1996 | 116 | 0 | |||
| Biomaterials in Ophthalmic Drug Delivery | European journal of pharmaceutics and biopharmaceutics | 1996 | 526 | 103 | |||
| The Use of Drug-Loaded Nanoparticles in Cancer Chemotherapy | Microencapsulation : methods and industrial applications | 1996 | 51 | 0 | |||
| Mucoadhesive Semi-Solid Formulations for Intraoral Use Containing Sucralfate | European journal of pharmaceutics and biopharmaceutics | 1996 | 311 | 184 | |||
| Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery | Journal of controlled release | 1996 | 98 | 0 | |||
| Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems | Biomaterials | 1996 | 514 | 2 | |||
| Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert | Pharmaceutical research | 1995 | 56 | 373 | |||
| Patent Literature Review of Ophthalmic Inserts | Drug development and industrial pharmacy | 1995 | 535 | 2 | |||
| The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester) | Journal of controlled release | 1995 | 87 | 0 | |||
| Use of Insoluble Biodegradable Polymers in Ophthalmic Systems for the Sustained Release of Drugs | European journal of pharmaceutics and biopharmaceutics | 1995 | 311 | 231 | |||
| Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation | Journal of controlled release | 1995 | 50 | 0 | |||
| Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels | Advanced drug delivery reviews | 1995 | 647 | 0 | |||
| New Approach for the Preparation of Nanoparticles by an Emulsification-Diffusion Method | European journal of pharmaceutics and biopharmaceutics | 1995 | 681 | 1,483 | |||
| PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary Tumours | Journal of Pharmacy and Pharmacology | 1995 | 152 | 0 | |||
| An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes | Life sciences | 1995 | 153 | 1 | |||
| Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice | Journal of pharmaceutical sciences | 1995 | 121 | 0 | |||
| Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery: validation and radiation effects | Pharmaceutical research | 1994 | 127 | 266 | |||
| In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymers | Journal of biomaterials science. Polymer ed | 1994 | 183 | 0 | |||
| Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil | Journal of biomedical materials research | 1994 | 160 | 0 | |||
| Application of Medical Imaging to Pharmaceutical Research: the Example of Gamma Scintigraphy. I: Technological Aspects | European journal of pharmaceutics and biopharmaceutics | 1994 | 197 | 29 | |||
| Long-term histopathological study of new polypeptidic biomaterials | Biomaterials | 1992 | 536 | 2 | |||
| Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size | International journal of pharmaceutics | 1992 | 683 | 2 | |||
| Aqueous nanodispersions prepared by a salting-out process | International journal of pharmaceutics | 1992 | 626 | 1 | |||
| Du fard des Egyptiens aux pseudo-latex : évolution des formes médicamenteuses en ophtalmologie | Cahiers de la Faculté des sciences / Université de Genève | 1982 | 7 | 13 |
